Cellanyx careers

Leveraging a proprietary diagnostic device, assay, and analytics, Cellanyx's testing service will use live-cell analysis of our patent-pending pool of biomarkers from a new and proprietary class of markers. Based on cellular behavior and bio-mechanics rather than gene sequences, Cellanyx will provide urologists predictive and quantitative measures of metastatic potential and local aggressiveness.